MPH Health Care

Earnings Release • Oct 22, 2009

News Details

Corporate | 22 October 2009 21:21

MPH Mittelständische Pharma Holding AG: Interim results showing success in growth

MPH Mittelständische Pharma Holding AG / Interim Report

22.10.2009

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Today, 22 October 2009, MPH Mittelständische Pharma Holding AG publishes
interim results as at 30 September 2009.

Results of MPH Group are fully affected by HAEMATO PHARM AG (100%
subsidiary). Interim Group accounts were not drawn up. Due to this, all key
figures following are those of HAEMATO PHARM AG (according to German
Commercial Code, HGB).

Within the first nine month 2009, HAEMATO PHARM AG achieved revenues of EUR
40.8 million. Revenues resulted by manufacturing and selling of
pharmaceuticals to pharmacies and to distributors working in this segment.

Compared to the first nine month 2008, revenues came up by more than 500
percent.

Approximately 44 percent or EUR 18 million of revenues relate to the third
quarter 2009.

Reporting periods EBIT came to EUR 2.7 million

About MPH Mittelständische Pharma Holding AG:

Berlin based MPH Mittelständische Pharma Holding AG is an investment
company within the pharmaceutical/healthcare sector. Core segments are
parallel imports (currently focussing oncology, rheumatology and HIV),
generic medicaments and wholesaling.

Based on strong growth, in 2009 it was possible to increase the number of
employees from 13 (30 September 2008) up to 31 (30 September 2009). All
employees are working in Berlin-Schönefeld. In this region, MPH is one of
the few companies clearly creating new jobs.

Since 1 September 2009, MPH Mittelständische Pharma Holding AG is listed in
the Open Market of Frankfurt stock exchange.

Key figures to the MPH share:

Capital stock EUR 38,050,000
Listed class of shares Bearer preferred share
Number of outstanding preferred shares 19,025,000
ISIN DE000A0NF697
Ticker symbol 93MV
Freefloat 2 percent*
Designated Sponsor Close Brothers Seydler Bank AG

* re-placement of stake of major shareholder Magnum AG in preparation

bonnIR
Hubert Bonn
Telefon: +49 (0)6157 9861190
Mailto: bonn@bonn-ir.com

22.10.2009 Financial News transmitted by DGAP

---